HomeNATCOPHARM • NSE
add
Natco Pharma Ltd
Nakaraang pagsara
₹775.50
Sakop ng araw
₹778.65 - ₹806.15
Sakop ng taon
₹726.80 - ₹1,639.00
Market cap
143.89B INR
Average na Volume
640.74K
P/E ratio
7.71
Dividend yield
0.75%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(INR) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 4.75B | -37.41% |
Gastos sa pagpapatakbo | 4.00B | 7.44% |
Net na kita | 1.33B | -37.47% |
Net profit margin | 28.01 | -0.11% |
Kita sa bawat share | 7.43 | -37.46% |
EBITDA | 368.00M | -86.02% |
Aktuwal na % ng binabayarang buwis | 19.12% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(INR) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 24.63B | 102.65% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 71.57B | — |
Natitirang share | 179.00M | — |
Presyo para makapag-book | 1.94 | — |
Return on assets | — | — |
Return on capital | -0.28% | — |
Cash Flow
Net change in cash
(INR) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 1.33B | -37.47% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
Itinatag
1981
Headquarters
Website
Mga Empleyado
4,016